Dermatol. praxi. 2017;11(1):6-11 | DOI: 10.36290/der.2017.002

Rosacea

doc. MUDr. Růžena Pánková, CSc.
Dermatovenerologická klinika 1. LF UK a VFN, Praha

Rosacea is a common, chronic, relapsing inflammatory skin condition consisting of various subtypes and degrees of severity.

In 2002, rosacea was classified and standardized by the National Rosacea Society Expert Committee into 4 recognized subtypes,

although these patterns often overlap in clinical practice. There are rarer pediatric and granulomatous presentations. Uncommon

skin condition is persistent edema of rosacea. Several theories regarding the etiology of rosacea exist: a genetic component, but

a rosacea gene has not been detected yet; an altered innate immune response; the presence of characteristic facial or ocular inflammation

involving both the vascular and tissue stroma. Patient education regarding trigger avoidance and skin care techniques

such as moisturizing and sun protection are important non-pharmacologic first steps in treating rosacea. The treatment of rosacea

including several topical drugs (ivermectin, metronidazole, antibiotics, azelaic acid, benzoyl peroxide, sulfacetamide/sulfur,

retinoids) and oral ones (mainly tetracyclines, metronidazole, macrolides, isotretinoin). The ideal medication choice dependent

on the symptoms and severity of each individual patient. None of these therapies are completely curative. Rosacea profound

effects on a person's psychological well-being. Therefore, treating rosacea can greatly affect a person's quality of life. Clinician

understanding and patient education are essential for compliance and successful treatment, with psychosomatic approach.

Keywords: an overview of rosacea, granulomatous rosacea, persistent edema of rosacea

Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pánková R. Rosacea. Dermatol. praxi. 2017;11(1):6-11. doi: 10.36290/der.2017.002.
Download citation

References

  1. Berth-Jones J. Rosacea. In Rook's Textbook of Dermatology, 8th edition, Edited by DA Burns, SM Breathnach, NH Cox and CEM Griffiths Copyright (C) 2010 by Blackwell Science Ltd.
  2. Adams Heather, Coven Chelsey, Grippe Kristen M. An Overview of Rosacea and Its Challenges. Review Article Physician Assistant Clinics, Volume 1, Issue 2, April 2016, Pages 255-264. Go to original source...
  3. Tüzün Yalç?n, MDa, Wolf Ronni, MDb, Zekayi Kutlubay, MDa, Özge Karakuş, MDa, Burhan Engin, MDa: Rosacea and rhinophyma. Clinics in Dermatology 2014; 32(1): 35-46. Go to original source... Go to PubMed...
  4. Aimee M. Two, Wiggin Wu, Richard L. Gallo, Tissa R. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors Review ArticleJ Am Acad Dermatol. 2015; 72(5): 749-758. Go to original source...
  5. Aimee M. Two, Wiggin Wu, Richard L. Gallo, Tissa R. Hata: Rosacea: Part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol 2015; 72(5): 761-770. Go to original source...
  6. Egeberg A, Hansen PR, Gislason GH, Tyssen JP. Clustering of Autoimmune Diseases in Patients With Rosacea J Am Acad Dermatol. 2016; 74: 667-672. Go to original source... Go to PubMed...
  7. Jones MP, Knable AL, White MJ, Durning SJ. Helicobacter pylori in rosacea. Lack of an association. Arch Dermatol 1998; 134: 511. Go to original source... Go to PubMed...
  8. Slonková V. Rosacea a dermatitis perioralis. Čes-slov 2009; 84(4): p. 183-192.
  9. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol, 2004; 51: p. 327-341. Go to original source... Go to PubMed...
  10. Nowak DA, HBSc, MD; Se Mang Wong, MD, FRCPC: DSM-5 Update in Psychodermatology Medscape the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5, published in 2013 by the American Psychiatric Association).
  11. Rulcová J. Kožní choroby postihující obličej. Referátový výběr z dermatovenerologie 2011; 53(III/speciál): 6-14.
  12. Rulcová J. Rosacea faciei - etiologie a patogeneze. Referátový výběr z dermatovenerologie 2013; 55(5): 1-5.
  13. Rulcová J. Přehled nejčastějších obličejových dermatóz I. část. Dermatol. praxi 2014; 8(3): 98-101.
  14. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46: 584e7. Go to original source... Go to PubMed...
  15. Vohradníková O. Obličejové dermatózy. Dermatol. praxi 2007; 1(3): 119-124.
  16. Rulcová J. Rosacea faciei - standardní klasifikace. Referátový výběr z dermatovenerologie 2013; 55(5): 6-11.
  17. Duchková H. Dermatitis perioralis. Dermatol. praxi 2008; 2(2): 85-87.
  18. Nevoralová Z. Závažná forma růžovky u 32leté pacientky Dermatol. praxi 2015; 9(3): 130-133.
  19. Duchková H. Trendy v léčbě periorální dermatitidy. Dermatol. praxi 2016; 10(1): 16-19. Go to original source...
  20. Benáková N. Rosacea. In Kuklová I, a kol. Dermatovenerologie pro všeobecné praktické lékaře. Ed. P. Herle, nakl. Dr, J. Raabe, s.r.o., ISBN 978-80-87553-28-2, 20011. p.157.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.